Actelis Networks, Inc. is a networking solutions company that implements communication for IoT projects. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create quick-to-deploy network. The firm develops broadband solutions for telecom service providers, enterprises and municipalities. It is accelerating broadband services to businesses and residential subscribers through Broadband Accelerator (BBA), EFMplus, Dynamic Rate Boost (DRB) and Dynamic Spectral Shaping (DSS). The company was founded by Yuval Baron, Tuvia Barlev and Kamran Elahian in 1997 and is headquartered in Fremont, CA.

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm's compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential. The CD40L/CD40 pathway is recognized for its prominent role in immune regulation, making it a candidate for therapeutic intervention in transplant tolerance, autoimmune disease, and neuro-inflammation. The company is building upon a deep historical understanding of the CD40/CD40L pathway, as well as preclinical and Phase 1 data, to initiate up to four phase 2 clinical studies with AT-1501. Eledon Pharmaceuticals was founded on March 26, 2004 and is headquartered in Irvine, CA.

Petros Pharmaceuticals, Inc. engages in men's health therapeutics. It is involved in sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. It operates through the Prescription Medications and Medical Devices segments. The Prescription Medications segment handles Stendra, a FDA approved PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction, and H100, a topical formulation candidate for the treatment of acute Peyronie's disease. The Medical Devices segment consists of vacuum erection devices. The company was founded on May 14, 2020 and is headquartered in New York, NY.

Fingermotion Inc. is a mobile data specialist company, which engages in the provision of payment and recharge service, data plans, subscription plans, mobile phones, loyalty points redemption, and other product bundles. It operates through the following segments: Telecommunications and Product Services, Value Added Products and Services, Short Message Services and Multimedia Messaging Services, Rich Communication Services Platform, and Big Data Insights. The company was founded on January 23, 2014, and is headquartered in Singapore.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.

Nano Labs Ltd. is a holding company, which engages in design and product solution provision of fabless integrated circuit. It offers high throughput computing chips, high performance computing chips, distributed computing and storage solutions, smart network interface cards, vision computing chips, and distributed rendering. The company was founded in July, 2019 and is headquartered in Hangzhou, China.

USIO, Inc. engages in providing integrated payment solutions. Its solutions include payment facilitation, merchant services, payment solutions, card issuing, check printing, electronic bill presentment & payment, and printing and mailing. The company offers services to software companies, merchants, billers, banks, service bureaus and card issuers. USIO was founded by Louis A. Hoch and Michael R. Long in July 1998 and is headquartered in San Antonio, TX.

Educational Development Corp. engages in the provision of educational children's books. It operates through the PaperPie and Publishing segments. The PaperPie segment sells books through independent consultants directly to customers by hosting home parties, through social media collaboration platforms on the internet, by hosting book fairs with school and public libraries. The Publishing segment sells its products to bookstores, toy stores, specialty stores, museums, and other retail outlets. The company was founded on August 23, 1965 and is headquartered in Tulsa, OK.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company engaged in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in San Francisco, CA.